170 related articles for article (PubMed ID: 8411447)
1. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.
Sklar GN; Eddy HA; Jacobs SC; Kyprianou N
J Urol; 1993 Nov; 150(5 Pt 1):1526-32. PubMed ID: 8411447
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
Kyprianou N; Rock S
Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
Palayoor ST; Bump EA; Teicher BA; Coleman CN
Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer.
Kyprianou N
World J Urol; 1994; 12(6):299-303. PubMed ID: 7881465
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
Cuellar DC; Rhee J; Kyprianou N
Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
[TBL] [Abstract][Full Text] [Related]
6. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
[TBL] [Abstract][Full Text] [Related]
7. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
Miyake H; Chi KN; Gleave ME
Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
[TBL] [Abstract][Full Text] [Related]
8. Transient tyrosine phosphorylation of p34cdc2 is an early event in radiation-induced apoptosis of prostate cancer cells.
Kyprianou N; Bains A; Rhee JG
Prostate; 1997 Sep; 32(4):266-71. PubMed ID: 9288185
[TBL] [Abstract][Full Text] [Related]
9. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.
Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME
Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro.
Wärri AM; Huovinen RL; Laine AM; Martikainen PM; Härkönen PL
J Natl Cancer Inst; 1993 Sep; 85(17):1412-8. PubMed ID: 8350365
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.
Kyprianou N; Bains AK; Jacobs SC
Prostate; 1994 Aug; 25(2):66-75. PubMed ID: 8036180
[TBL] [Abstract][Full Text] [Related]
13. Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer.
Gleave ME; Miyake H; Zellweger T; Chi K; July L; Nelson C; Rennie P
Urology; 2001 Aug; 58(2 Suppl 1):39-49. PubMed ID: 11502446
[TBL] [Abstract][Full Text] [Related]
14. Radiation inactivation of human prostate cancer cells: the role of apoptosis.
Algan O; Stobbe CC; Helt AM; Hanks GE; Chapman JD
Radiat Res; 1996 Sep; 146(3):267-75. PubMed ID: 8752304
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.
Yamanaka K; Gleave ME; Hara I; Muramaki M; Miyake H
Mol Cancer Ther; 2005 Feb; 4(2):187-95. PubMed ID: 15713890
[TBL] [Abstract][Full Text] [Related]
16. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
Shankar S; Singh TR; Srivastava RK
Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells.
Kyprianou N; King ED; Bradbury D; Rhee JG
Int J Cancer; 1997 Jan; 70(3):341-8. PubMed ID: 9033638
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review).
Szostak MJ; Kyprianou N
Oncol Rep; 2000; 7(4):699-706. PubMed ID: 10854529
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
Kyprianou N; English HF; Isaacs JT
Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model.
Zellweger T; Kiyama S; Chi K; Miyake H; Adomat H; Skov K; Gleave ME
BJU Int; 2003 Sep; 92(4):463-9. PubMed ID: 12930442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
